VEGFR1/Flt-1 Antibody (FLT1/658) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-34618JF669
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # FLT1/658
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human VEGFR1/Flt-1 protein (Uniprot: P17948)
Localization
Cell surface
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for VEGFR1/Flt-1 Antibody (FLT1/658) [Janelia Fluor® 669]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VEGFR1/Flt-1
Long Name
Vascular Endothelial Growth Factor Receptor 1
Alternate Names
Flt-1, FLT1, FRT, VEGF R1, VEGFR-1
Gene Symbol
FLT1
Additional VEGFR1/Flt-1 Products
Product Documents for VEGFR1/Flt-1 Antibody (FLT1/658) [Janelia Fluor® 669]
Product Specific Notices for VEGFR1/Flt-1 Antibody (FLT1/658) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...